Skip to Content
View site list

Profile

Pre-Bid Projects

Pre-Bid Projects

Click here to see Canada's most comprehensive listing of projects in conceptual and planning stages

Others

Diamond Schmitt Architects to design cancer research lab space at MaRS in Toronto

Daily Commercial News

Diamond Schmitt Architects will design research laboratory space for the Ontario Institute for Cancer Research (OICR) at the MaRS phase 2 west tower currently under construction in downtown Toronto.

The program includes wet and dry laboratories for genomics and informatics research as well as data processing on the fifth and sixth floors of the new building.


View Larger Map

This new facility significantly expands existing OICR research activity located in the MaRS Centre.

Daily Commercial News subscribers may view more information on Diamond Schmitt Architects and its construction projects by viewing company ID 638753 in Reed Construction Data Canada Building Reports.

If you are not already a subscriber, you can be by filling out the form at this web page.

Building Reports are published daily in the Daily Commercial News. The Daily Top 10 Construction projects can be viewed online free of charge at the Reed Construction Data Canada Building Reports web page.

To learn more about construction project leads from Reed Construction Data, fill out the web form at this web page.

“This facility fosters the important interconnectivity among researchers by providing for shared amenity space,” said Donald Schmitt, principal at Diamond Schmitt Architects.

Large meeting rooms, kitchens, a library and social spaces are located near the convenience stair between the two floors. Additionally, a two-level sky bridge will connect to existing OICR facilities in the MaRS south tower.

All workstations will have access to exterior views and natural light where function allows. The sixth floor wet labs are modular with open concept island benches. Adjacent core support labs include shared facilities for tissue and bacterial culture, microscopy and other functions.

“This expansion will enable OICR to increase the capacity of its genomics and bioinformatics programs which are at the heart of our personalized medicine initiatives,” said Dr. Tom Hudson, OICR’s president and scientific director.

“We will be working in a unique environment designed for our needs.”

The facility is slated for occupancy in the fall of 2013.

DCN NEWS SERVICES

Recent Comments

comments for this post are closed